L-Baclofen

DB12098InvestigationalSmall molecule

L-Baclofen has been used in trials studying the treatment of Trigeminal Neuralgia.

Chemical structure of L-Baclofen
Formula / weight
C10H12ClNO2 · 213.66 g/mol (avg)
Also known as
(S)-Baclofen

Resolves to

Compound
UNII3OHN4989XMCAS66514-99-6ChEMBLCHEMBL302213PubChem44600
Structure
InChIKeyKPYSYYIEGFHWSV-MRVPVSSYSA-NSMILESNC[C@@H](CC(O)=O)C1=CC=C(Cl)C=C1
Targets
Q9UBS5GABBR1

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with L-Baclofen, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In